单孔胸腔镜下肺叶与肺段切除术在高龄早期肺癌患者中短期临床疗效

Clinical analysis of uniportal thoracoscopic lobectomy and segmental lung resection in elderly patients with early lung cancer

目的探讨肺段切除与肺叶切除在高龄Ⅰ期非小细胞肺癌(NSCLC)患者中的应用并对比其临床疗效。方法选取2018年8月至2020年2月成功施行单孔全胸腔镜手术切除的269例高龄NSCLC患者,其中肺叶切除186例,肺段切除83例,分析两组临床病例资料。结果在肺段切除与肺叶切除两组资料中,两组均无近期严重并发症及死亡患者,术中清扫淋巴结总数及淋巴结站数的比较中,肺叶组均大于肺段组,术后并发症的比较中,肺叶组术后心律失常的发生较肺段组多。两组患者手术时间、术中出血量、术后引流量、术后住院时间、住院费用差异无统计学意义。结论单孔胸腔镜下肺段切除术与肺叶切除应用于高龄NSCLC安全、有效,肺段切除对比肺叶切除可以达到临床近期相似的效果,甚至有可能更有利于患者恢复。

Objective To evaluate the clinical efficacy of segmental lung resection versus lobectomy in elderly patients with non-small cell lung carcinoma stage I.Methods A total of 171 elderly patients with nonsmall cell lung cancer underwent uniportal thoracoscopic resection from August 2018 to August 2019,including 120 lobectomy and 51 segmental resection,the clinical data of the two groups were analyzed.Results In the two groups of pulmonary segmental resection and lobectomy,there were no recent serious complications and death in the two groups.In the comparison of the total number of lymph nodes and the number of lymph node stations,the pulmonary lobe group was larger than the pulmonary segment group,the incidence of postoperative Arrhythmia in Lobar group was more than that in segment group.There was no significant difference in operation time,intraoperative bleeding,postoperative drainage,postoperative hospitalization time and hospitalization expenses between the two groups.Conclusion Both uniportal thoracoscopic segmental lung resection and lobectomy are safe and effective in the treatment of elderly patients with pulmonary non-small-cell lung carcinoma,and have similar clinical results in the near future,while segmental lung resection might be better for the patient's recovery.